Richelle M. Mychasiuk

Richelle M. Mychasiuk

PhD, MSc-Forensic Molecular Biology, BSc-Psychology, BSc-Cellular, Molecular & Microbial Biology

Neurologist

16 years of Experience

Female📍 Melbourne

About of Richelle M. Mychasiuk

Richelle M. Mychasiuk is a neurologist based in Melbourne, working from the 6th Floor, 99 Commercial Road, Melbourne VIC 3004, Australia.


Neurology can be a big word, but the day-to-day work is very practical. Dr Mychasiuk looks after people dealing with ongoing brain and nerve issues, as well as concerns after an injury. This can include concussion and traumatic brain injury, and the problems that sometimes come along with them later on.


Her work also covers long-term conditions where the nervous system is causing ongoing symptoms. That might mean headaches or nerve pain like trigeminal neuralgia, or different types of seizures and epilepsy. Some people are dealing with seizures that come and go, and others need help after changes linked to brain injury. In some cases, she also supports people with issues like cerebral hypoxia, and worries that can show up after infections that affect the brain.


At times, neurologic symptoms can overlap with mental health and stress, especially after a traumatic event. Dr Mychasiuk understands that connection and considers the bigger picture, including post-traumatic stress disorder (PTSD). She also works with families where autism spectrum disorder is part of the overall health story, particularly when there are nervous system symptoms alongside it.


Over time, patients often come to neurology because they need answers and a clear plan. Dr Mychasiuk focuses on understanding what’s going on, what might be driving symptoms, and how treatment can fit into real life. The goal is to help people get stable and feel more confident about what to do next, not just get through one appointment.


Dr Mychasiuk has 16 years of experience. Her training includes a PhD in Neuroscience from the University of Lethbridge (2012). She also holds a Master of Science in Forensic Molecular Biology from George Washington University (2007), plus two Bachelor of Science degrees from the University of Calgary: Psychology (2005) and Cellular, Molecular & Microbial Biology (2005).


Research matters in neurology, and her background reflects that. Where relevant, she works with the best available evidence to guide care. Clinical trials are not always the right fit for every person, so the focus stays on what can help each patient most.


If you’re looking for a neurologist who keeps things calm, clear, and grounded, Dr Richelle M. Mychasiuk is a thoughtful choice.

Education

  • PhD - Neuroscience; University of Lethbridge; 2012
  • MSc - Forensic Molecular Biology; George Washington University; 2007
  • Bachelor of Science - Psychology; University of Calgary; 2005
  • Bachelor of Science - Cellular, Molecular & Microbial Biology; University of Calgary; 2005

Services & Conditions Treated

Chronic PainConcussionTraumatic Brain InjuryCerebral HypoxiaNeuralgiaSeizuresToxoplasmosisAbsence of TibiaAbsence SeizureAcute PainAutism Spectrum DisorderEpilepsyEpilepsy Juvenile AbsenceGanglion CystGeneralized Tonic-Clonic SeizurePartial Familial EpilepsyPost-Traumatic EpilepsyPost-Traumatic Stress Disorder (PTSD)Status EpilepticusTrigeminal Neuralgia

Publications

5 total
Sex and Age-at-Injury as Determinants of Social Behavior Outcomes After TBI.

Advances in neurobiology • October 21, 2024

Bridgette Semple, Richelle Mychasiuk

While our understanding of long-term disability after traumatic brain injury (TBI) has habitually focused on cognitive and sensorimotor functioning, it is increasingly appreciated that changes in social function for survivors of a brain injury are common and have a profound impact on one's quality of life. In this chapter, we highlight the consequences of TBI on social behavior, taking into account evidence from studies of patient populations as well as from preclinical animal models. After first considering the protracted nature of the development of social behavior across the lifespan, including the neurobiological networks that underlie social functioning, we discuss how TBI results in social behavior impairments and how these manifest. We focus particularly on how age-at-injury influences TBI-induced social impairments, with most of the evidence suggesting age-dependent vulnerability after injury at a younger age. In addition, we explore how biological sex is a key determinant of social behavior impairments after TBI, while gender in humans may also influence the nature and extent of social outcomes. Finally, we identify key knowledge gaps and emphasize the need for further research in the field.

Maternal oxytocin administration mitigates nociceptive, social, and epigenetic impairments in adolescent offspring exposed to perinatal trauma.

Neurotherapeutics : The Journal Of The American Society For Experimental NeuroTherapeutics • January 23, 2025

Sydney Harris, Zoe Kodila, Sabrina Salberg, Marissa Sgro, Elaina Vlassopoulos, Crystal Li, Madeleine Smith, Sandy Shultz, Glenn Yamakawa, Melanie Noel, Richelle Mychasiuk

Adverse childhood experiences (ACEs) alter brain development, leading to vulnerability for chronic pain, mental health disorders, and suicidality. These effects often emerge during adolescence. Importantly, ACEs can occur prenatally, including when exposed to in utero intimate partner violence (IPV) or postnatally as maternal neglect. Maternal social support has demonstrated promise in the mitigation of ACE-related deficits. Oxytocin, which has a role in social-bonding and stress regulation, serves as a suitable surrogate for social support in preclinical studies. Therefore, we aimed to explore the effects of oxytocin on alleviating social deficits, nociception, and epigenetic changes resulting from models that aimed to mimic the stress normally induced following exposure to two ACEs: IPV in utero and maternal neglect. During pregnancy, dams were randomly assigned to experience the model of IPV or a sham insult. Following birth, offspring from the IPV group underwent 10 days of maternal separation. Dams received three days of oxytocin therapy while nursing. In adolescence, half of the offspring underwent a plantar surgery to induce pain. Overall, in adolescence, rats exposed to the ACEs exhibited increased nociceptive sensitivity and aberrant social interactions, particularly among males, further suggesting that ACEs can increase an individual's risk for chronic pain. The ACEs changed gene expression related to social behaviour and neuroplasticity. Maternal oxytocin normalized pain, social, and gene changes, while oxytocin levels in offspring correlated with nociceptive sensitivity. Although ACEs have enduring consequences, the outcomes are modifiable, and oxytocin may be a robust and implementable therapeutic capable of attenuating early adversity.

Shaking into deficits: investigating behavioural and neuropathological outcomes associated with a novel preclinical model of infant abusive head trauma.

Acta Neuropathologica Communications • January 17, 2025

Sydney Harris, Marissa Sgro, Sabrina Salberg, Crystal Li, Elaina Vlassopoulos, Madeleine Smith, Bridgette Semple, Holly Chinnery, Richelle Mychasiuk

Abusive head trauma (AHT) resulting from violent shaking and whiplash-induced brain injury by a caregiver, is the leading cause of abusive mortality and morbidity in children. Cerebral oedema is common in survivors of AHT. While many children may initially appear behaviourally asymptomatic or present with non-specific symptoms following the AHT, deficits often emerge later in childhood. Additionally, AHTs are frequently repetitive, with a single child likely to experience multiple AHTs. Despite the prevalence of AHT, the mechanisms that lead to brain pathology and the latent emergence of behavioural deficits are poorly understood, and there is a paucity of preclinical, small animal models to investigate the biology and cumulative effects of repetitive injuries. This study aimed to develop a preclinical model of repetitive AHT and subsequently examine alterations in gene expression, cell types, and early adolescent behaviour. Mice were placed on a 400 rpm shaking device for 60s. This was repeated one, three, or five times throughout the neonatal development period (postnatal days (P)8-12). Injured mice initially displayed no overt behavioural changes compared to uninjured controls; however, in adolescence (P40-45) they later developed deficits in socialisation and thermal nociception. Further, alterations in the expression of genes involved in growth, cell damage, and development were observed in the brains of injured mice, along with an increase in white matter cells and evidence of blood-brain barrier leakage. This novel preclinical model of AHT provides a valuable platform for exploring diagnostic biomarkers and potential therapeutic interventions for children with an AHT.

Does the brain's vestibular system contribute to synchronisation of circadian rhythms?

Neuroscience And Biobehavioral Reviews • January 15, 2025

Elaina Vlassopoulos, Richelle Mychasiuk, Glenn Yamakawa

The primary circadian clock in the brain, the suprachiasmatic nucleus (SCN), drives ∟24-hour circadian rhythms that help regulate physiology and behaviour. To conform to the environment, circadian rhythms are entrained to zeitgebers "time givers", external cues that assist in resetting of the circadian clock and shift the timing of its rhythms. The primary zeitgeber is light, which is considered a photic input. Additional zeitgebers that can modify circadian rhythms independent of light are known as non-photic stimuli, and are innervated by arousal regions of the brain. The mechanisms by which non-photic stimuli contribute to resetting of the circadian clock are currently not clear; however, evidence indicates that activation of arousal regions is necessary. A concept not yet investigated is the involvement of the sensory vestibular system in non-photic clock resetting. Therefore, this review synthesizes current literature and proposes a novel role for the vestibular system in resetting the circadian clock in a non-photic manner. By providing insight into the potential role of vestibular regulation in circadian rhythmicity, we provide valuable evidence that can be used in the future to develop strategies to mitigate circadian misalignment and subsequent dysfunction.

The effect of traumatic brain injury on learning and memory: A synaptic focus.

The Neuroscientist : A Review Journal Bringing Neurobiology, Neurology And Psychiatry • September 24, 2024

Eric Eyolfson, Kirsten R Suesser, Holly Henry, Itziar Bonilla Del RĂ­o, Pedro Grandes, Richelle Mychasiuk, Brian Christie

Deficits in learning and memory are some of the most commonly reported symptoms following a traumatic brain injury (TBI). We will examine whether the neural basis of these deficits stems from alterations to bidirectional synaptic plasticity within the hippocampus. Although the CA1 subregion of the hippocampus has been a focus of TBI research, the dentate gyrus should also be given attention as it exhibits a unique ability for adult neurogenesis, a process highly susceptible to TBI-induced damage. This review examines our current understanding of how TBI results in deficits in synaptic plasticity, as well as how TBI-induced changes in endocannabinoid (eCB) systems may drive these changes. Through the synthesis and amalgamation of existing data, we propose a possible mechanism for eCB-mediated recovery in synaptic plasticity deficits. This hypothesis is based on the plausible roles of CB1 receptors in regulating inhibitory tone, influencing astrocytes and microglia, and modulating glutamate release. Dysregulation of the eCBs may be responsible for deficits in synaptic plasticity and learning following TBI. Taken together, the existing evidence indicates eCBs may contribute to TBI manifestation, pathogenesis, and recovery, but it also suggests there may be a therapeutic role for the eCB system in TBI.

Frequently Asked Questions

What services does Dr Richelle M. Mychasiuk offer?
Dr Richelle M. Mychasiuk specializes in neurological conditions and offers services related to chronic pain, concussion, traumatic brain injury, cerebral hypoxia, neuralgia, seizures (including absence seizures and post-traumatic epilepsy), PTSD, autism spectrum disorder, epilepsy and related disorders, trigeminal neuralgia, ganglion cysts, and other related neurological issues.
Which conditions can I discuss with her in an appointment?
You can discuss conditions such as epilepsy and various seizure types, post-traumatic conditions, chronic and acute pain, concussion and brain injuries, PTSD, autism spectrum concerns, trigeminal neuralgia, and other neurological symptoms you’re worried about.
Where is the clinic located and how can I book an appointment?
The clinic is on the 6th Floor, 99 Commercial Road, Melbourne, VIC 3004. To book an appointment, please contact the practice directly through the usual booking channels provided by the clinic.
What should I bring to my first appointment?
Bring any relevant medical records, imaging or test results, a list of current medications, and notes about your symptoms and medical history to help the appointment run smoothly.
What can I expect in a neurology appointment with Dr Mychasiuk?
The appointment will focus on assessing neurological symptoms, reviewing your history, and discussing investigations or treatments relevant to your condition. The neurologist will explain the findings in plain language and discuss next steps.
Will Dr Mychasiuk treat conditions in both adults and children?
Dr Mychasiuk treats a range of neurological conditions. If you have questions about paediatric care or specific age-related concerns, please contact the clinic to confirm suitability for your situation.

Contact Information

6th Floor, 99 Commercial Road, Melbourne, VIC 3004, Australia

Is this your profile?

Claim this profile →

Memberships

  • Canadian Concussion Network
  • Hotchkiss Brain Institute (University of Calgary)
  • Open Science Framework (OSF)